Factors associated with viral load suppression among children and adolescents on dolutegravir-based antiretroviral regimen in Tanzania: a longitudinal analysis

Related articles

1. Closing the Gaps in Pediatric and Adolescent HIV Care: Viral Suppression and Adverse Events after 2018 Antiretroviral Optimization in Uganda

   This article has 6 authors:

   1. Collins Ankunda
   2. Sharon Namasambi
   3. Brendah Kyomuhangi
   4. Jude Emunyu
   5. Conrad Sserunjogi
   6. Jane Nakaweesi

2. Dolutegravir-Based Therapy is Essential in Achieving HIV Epidemic Control in Low- and Middle-Income Countries: Real-Life Evidence from a Large Clinical Cohort in Cameroon

   This article has 28 authors:

   1. Carine Tadenfok
   2. Joseph Fokam
   3. Ezechiel Ngoufack Jagni Semengue
   4. Leonella Mossiang
   5. Steve Oyie
   6. Pascaline Noumo
   7. judith Ngia
   8. Grace Angong Beloumou
   9. Sandrine Djupsa
   10. Alex Durand Nka
   11. Collins Chenwi Ambe
   12. Aude Christelle Ka’e
   13. Desire Takou
   14. Derrick Tambe Ayuk Ngwese
   15. Tatiana Tekoh Anim-keng
   16. Lum Forgwei
   17. Angeline Kengne
   18. Bouba Yagai
   19. Elong Lobe Elise
   20. Ariane Feukeng
   21. Rogers Ajeh Awoh
   22. Anne-Cecile ZK Bissek
   23. Marius Vouking
   24. Alexis Ndjolo
   25. Nicaise Ndembi
   26. Carlo-Federico Perno
   27. Charles Kouanfack
   28. Celine Nkenfou

3. Study on the current status and influencing factors of viral load non- suppression among patients with HIV and AIDS receiving antiretroviral therapy

   This article has 4 authors:

   1. Bahejianati Nuerbolati
   2. Yaling Du
   3. Wenying He
   4. Songsong Xie